**Author details**

Neerja Aggarwal1 and Pawan Kumar Kare2 \*

1 Department of Medicine, University College of Medical Sciences and Guru Teg Bahadur Hospital, Delhi, India

2 Department of Medical Biochemistry, Gandhi Medical College, Bhopal, India

\*Address all correspondence to: pawankare4@gmail.com

© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**187**

2017;8(2).

*Diabetes Microvascular Complications: An Overview of Epigenetic Modifications*

and without diabetic nephropathy: Incidence and risk factors. Diabetologia.

[9] Seidegård J, Vorachek WR, Pero RW, Pearson WR. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion.

Proceedings of the National Academy of

Sciences. 1988;**85**(19):7293-7297

2014;**41**(4):2287-2298

2013;**372**(1-2):191-198

[10] Amal S, Zidan HE, Rashad NM. Adiponectin gene polymorphisms in Egyptian type 2 diabetes mellitus patients with and without diabetic nephropathy. Molecular biology reports.

[11] Shah VN, Cheema BS, Sharma R, Khullar M, Kohli HS, Ahluwalia TS, et al. ACACβ gene (rs2268388) and AGTR1 gene (rs5186) polymorphism and the risk of nephropathy in Asian Indian patients with type 2 diabetes. Molecular and Cellular Biochemistry.

[12] Deshmukh H, Palmer C, Morris A, Colhoun H. Investigation of known estimated glomerular filtration rate loci in patients with type 2 diabetes. Diabetic

medicine. 2013;**30**(10):1230-1235

[13] Hussain H, Ramachandran V, Ravi S, Sajan T, Ehambaram K, Gurramkonda VB, et al. TCF7L2 rs7903146 polymorphism and diabetic

nephropathy association is not independent of type 2 diabetes—A study in a south Indian population and meta-analysis. Endokrynologia Polska.

Endocrine. 2011;**40**(3):372-378

[15] Nazir N, Siddiqui K, Al-Qasim S, Al-Naqeb D. Meta-analysis of diabetic

[14] Jia H, Yu L, Gao B, Ji Q. Association between the T869C polymorphism of transforming growth factor-beta 1 and diabetic nephropathy: A meta-analysis.

2014;**65**(4):298-305

1987;**30**(3):144-148

*DOI: http://dx.doi.org/10.5772/intechopen.94642*

Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New England Journal of Medicine. 2001;**344**(18):1343-1350

[2] Association AD. 2. Classification and diagnosis of diabetes. Diabetes care. 2015;38(Supplement 1):S8-S16.

[3] Atlas D. International, Federation D. IDF Diabetes Atlas. 7th ed. International Diabetes Federation: Brussels, Belgium;

[4] Anjana RM, Deepa M, Pradeepa R, Mahanta J, Narain K, Das HK, et al. Prevalence of diabetes and prediabetes in 15 states of India: Results from the ICMR–INDIAB population-based crosssectional study. The Lancet Diabetes & Endocrinology. 2017;**5**(8):585-596

[5] Zhao Y, Ye W, Boye KS,

among patients with diabetic

Complications. 2010;**24**(1):9-19

prevention. 2013;**2**(2):73

[6] Shahbazian H, Rezaii I. Diabetic kidney disease; review of the current knowledge. Journal of renal injury

[7] Rajput R, Kumar K, Seshadri K, Agarwal P, Talwalkar P, Kotak B, et al. Prevalence of chronic kidney disease (CKD) in type 2 diabetes mellitus patients: START-India study. JOURNAL OF DIABETES & METABOLISM.

[8] Jensen T, Borch-Johnsen K, Kofoed-Enevoldsen A, Deckert T. Coronary heart disease in young type 1 (insulindependent) diabetic patients with

Holcombe JH, Hall JA, Swindle R. Prevalence of other diabetes-associated complications and comorbidities and its impact on health care charges

neuropathy. Journal of Diabetes and its

[1] Tuomilehto J, Lindström J,

**References**

2015

*Diabetes Microvascular Complications: An Overview of Epigenetic Modifications DOI: http://dx.doi.org/10.5772/intechopen.94642*
